Every wellness clinic is only as successful as the capabilities of its software. Here's where you can find the top-rated practice management solutions for med spas.
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like Blue Shield of California and Evernorth have undergone CEO exits. There were also layoffs at organizations including HHS, Blue Cross of Idaho and the University of Pennsylvania Health System.
Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early look at Phase 1/2 data fell short of efficacy goals. This program came from a $950 million acquisition in 2019 that marked Vertex's entry into type 1 diabetes.
Engaging in data sharing, observational cohort research, and deeper analysis of available data to yield further insights can drive improved results for patients, making label and cohort extension faster and more robust.
The Trump administration is eliminating about $4 billion in NIH funding. When reporting on the impact of this change, Assistant Editor Katie Adams examined the success of NIH-funded research — how often does this research lead to new drugs or commercialized technologies?
Leasing allows healthcare facilities more freedom to acquire up-to-date medical equipment without the need for immediate capital investment, opening doors for smaller and newer enterprises.
In this episode, we're joined by Dr. Audrey Jiricko, senior medical director of women's health at Intermountain Health. She discusses how the organization is screening women for intimate partner violence.
No comments